Alpha inflation in two stage design [Two-Stage / GS Designs]

posted by kumarnaidu – Mumbai, India, 2013-12-04 14:43 (4153 d 11:04 ago) – Posting: # 11999
Views: 24,741

Hi all,
In one of BEBAC presentation Page 45 http://bebac.at/lectures/Prague2012-2.pdf
a below statement is written.
Deficiency 2: The Applicant should demonstrate that the
type I error inflation which can be expected from the
chosen approach, did not impact on the decision of
bioequivalence.

Response 2: One million simulations based on study’s
sample size and CV.
αemp 0.0494 (95% CI: 0.0490 – 0.049)

Here I want to ask if I want to demonstrate that type error inflation did not impact on my study then can I demonstrate this by simply showing 90% CI as well as 94.12% CI for GMR of PK parameters within the acceptance limits (80% to 125%).
also I am not getting how to interpret Response 2

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,709 registered users;
41 visitors (0 registered, 41 guests [including 9 identified bots]).
Forum time: 02:48 CEST (Europe/Vienna)

Do not put your faith in what statistics say until you have carefully
considered what they do not say.    William W. Watt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5